Elicio’s KRAS cancer vaccine fails in Phase 2, shares plummet

June 15, 2026 11:42 AM EDT R&D Eli­cio’s KRAS can­cer vac­cine fails in Phase 2, shares plum­met Lei Lei Wu News Reporter Eli­cio Ther­a­peu­tics’ pan­cre­at­ic can­cer vac­cine failed to im­prove out­comes in a mid-stage study, but the com­pa­ny is seek­ing funds to move ahead to a larg­er … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER